Goldbaum Andrew M MD entered the industry of Ophthalmologists in 2000 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 6211110, which describes it as a Ophthalmologists. For further clarification, the SIC classifies this business under the code 8011 and described it as a Ophthalmologists. The business provides service to the B2C market.
To acquire more information, please contact Andrew Goldbaum by calling (212) 288-2800 during business hours. You can also write to the business’ Single Location at 605 Park Avenue # 1b, New York City, New York NY 10065. You can also visit the company’s website at drgoldbaum.com. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Goldbaum Andrew M MD |
Representative: | Andrew Goldbaum |
Place of Business: | 605 Park Avenue # 1b, New York City, NY 10065 |
Contact Number: | (212) 288-2800 |
Website: | drgoldbaum.com |
Type of Service: | Ophthalmologists |
SIC Number: | 8011 |
NAICS Number: | 6211110 |
Locality: | Single Location |
Market Type: | B2C (Business to Consumer) |
Began: | 2000 |
Income/Year: | $500.000 to $999.999 |
Laborers: | 1 to 4 |
Share This Company: |
Goldbaum Andrew M MD is a company operating from New York, New York providing professional Ophthalmologists and relevant B2C variables. It was founded in 2000 and registered with the SIC code 8011 as Ophthalmologists, and with the NAICS code 6211110 as Ophthalmologists.
With a current employee count of 1 to 4, Goldbaum Andrew M MD has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Andrew Goldbaum at (212) 288-2800 for related queries, or to locate its Single Location using the coordinates 40.766164,-73.967345.
The Single Location can also be found at the street address 605 Park Avenue # 1b in New York City, New York 10065 and can be engaged online through the company website at drgoldbaum.com, the company Twitter , and Facebook page .